scholarly journals Prevalence of adverse drug events and adverse drug reactions in hospital among older patients with dementia: A systematic review

Author(s):  
Marissa Anne Sakiris ◽  
Mouna Sawan ◽  
Sarah Nicole Hilmer ◽  
Rebecca Awadalla ◽  
Danijela Gnjidic
2020 ◽  
Vol 49 (6) ◽  
pp. 948-958 ◽  
Author(s):  
Emma L M Jennings ◽  
Kevin D Murphy ◽  
Paul Gallagher ◽  
Denis O’Mahony

Abstract Background the prevalence of adverse drug reactions (ADRs) in hospitalised older patients, their clinical presentations, causative drugs, severity, preventability and measurable outcomes are unclear, ADRs being an increasing challenge to older patient safety. Methods we systematically searched PubMed, Embase, EBSCO-CINAHL, the Cochrane Library, ‘rey’ literature and relevant systematic review bibliographies, published from database inception to March 2020. We included any study reporting occurrence of in-hospital ADRs as primary or secondary outcomes in hospitalised older adults (mean age ≥ 65 years). Two authors independently extracted relevant information and appraised studies for bias. Study characteristics, ADR clinical presentations, causative drugs, severity, preventability and clinical outcomes were analysed. Study estimates were pooled using random-effects meta-analytic models. Results from 2,399 abstracts, we undertook full-text screening in 286, identifying 27 studies (29 papers). Final analysis yielded a pooled ADR prevalence of 16% (95%CI 12–22%, I2 98%,τ2 0.8585), in a population of 20,153 hospitalised patients aged ≥65 years of whom 2,479 patients experienced ≥ one ADR. ADR ascertainment was highly heterogeneous. Almost 48.3% of all ADRs involved five presentations: fluid/electrolyte disturbances (17.3%), gastrointestinal motility/defaecation disorders (13.3%), renal disorders (8.2%), hypotension/blood pressure dysregulation disorders/shock (5.5%) and delirium (4.1%). Four drug classes accounted for 57.8% of causative medications i.e. diuretics (19.8%), anti-bacterials (14.8%), antithrombotic agents (12.2%) and analgesics (10.9%). Pooled analysis of severity was not feasible. Four studies reported the majority of ADRs as preventable (55–95%). Conclusions on average, 16% of hospitalised older patients experience significant ADRs, varying in severity and mostly preventable, with commonly prescribed drug classes accounting for most ADRs.


CNS Drugs ◽  
2021 ◽  
Vol 35 (2) ◽  
pp. 161-176
Author(s):  
Israa Alfares ◽  
Muhammad Shahid Javaid ◽  
Zhibin Chen ◽  
Alison Anderson ◽  
Ana Antonic-Baker ◽  
...  

2018 ◽  
Vol 47 (suppl_5) ◽  
pp. v13-v60 ◽  
Author(s):  
Emma Jennings ◽  
Kevin Murphy ◽  
Paul Gallagher ◽  
Denis O’Mahony

Author(s):  
Lesley K Bowker ◽  
James D Price ◽  
Sarah C Smith

Pharmacology in older patients 126 Prescribing ‘rules’ 128 Taking a drug history 130 HOW TO . . . Improve concordance 132 Drug sensitivity 134 Adverse drug reactions 135 ACE inhibitors 136 HOW TO . . . Start ACE inhibitors 137 Amiodarone 138 HOW TO . . . Manage amiodarone-induced thyroid dysfunction 139 Analgesia 140...


Sign in / Sign up

Export Citation Format

Share Document